UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Double heterozygosity for TP53 and BRCA1 mutations: clinical implications in populations with founder mutations

Breast cancer research and treatment, 2021-02, Vol.186 (1), p.259-263

2021

Volltextzugriff (PDF)

Activating genomic alterations in the Gs alpha gene (GNAS) in 274 694 tumors

Genes chromosomes & cancer, 2020-09, Vol.59 (9), p.503-516

2020

Volltextzugriff (PDF)

Time trends in uptake rates of risk-reducing mastectomy in Israeli asymptomatic BRCA1 and BRCA2 mutation carriers

Breast cancer research and treatment, 2021, Vol.185 (2), p.391-399

2021

Volltextzugriff (PDF)

De novo pathogenic germline variant in PALB2 in a patient with pancreatic cancer

Familial cancer, 2020-04, Vol.19 (2), p.193-196

2020

Volltextzugriff (PDF)

Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers

Cancer, 2019-03, Vol.125 (5), p.698-703

2019

Volltextzugriff (PDF)

Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers

BMC cancer, 2022-06, Vol.22 (1), p.1-706, Article 706

2022

Volltextzugriff (PDF)

Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants

Breast cancer research and treatment, 2020-06, Vol.181 (2), p.445-453

2020

Volltextzugriff (PDF)

Breast cancer surveillance for BRCA1/2 mutation carriers – is “early detection” early enough?

Breast (Edinburgh), 2020-02, Vol.49, p.81-86

2020

Volltextzugriff (PDF)

Age at diagnosis of cancer in 185delAG BRCA1 mutation carriers of diverse ethnicities: tentative evidence for modifier factors

Familial cancer, 2021-07, Vol.20 (3), p.189-194

2021

Volltextzugriff (PDF)

Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers

European journal of human genetics : EJHG, 2018-03, Vol.26 (3), p.382-386

2018

Volltextzugriff (PDF)

Cancer risks in Jewish male BRCA1 and BRCA2 mutation carriers

Breast cancer research and treatment, 2015-04, Vol.150 (3), p.631-635

2015

Volltextzugriff (PDF)

The risk for developing cancer in Israeli ATM, BLM, and FANCC heterozygous mutation carriers

Cancer genetics, 2016-03, Vol.209 (3), p.70-74

2016

Volltextzugriff (PDF)

Population‐based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants

Molecular genetics & genomic medicine, 2022-06, Vol.10 (6), p.e1928-n/a

2022

Volltextzugriff (PDF)

The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation

Journal of neurology, 2009-03, Vol.256 (3), p.483-487

2009

Volltextzugriff (PDF)

Association between variants of 5-hydroxytryptamine receptor 3C (HTR3C) and chemotherapy-induced symptoms in women receiving adjuvant treatment for breast cancer

Breast cancer research and treatment, 2014-02, Vol.144 (1), p.123-131

2014

Volltextzugriff (PDF)

Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families

Familial cancer, 2012-09, Vol.11 (3), p.483-491

2012

Volltextzugriff (PDF)

Phenotypes of carriers of two mutated alleles in major cancer susceptibility genes

Breast cancer research and treatment, 2024-08

2024

Volltextzugriff (PDF)

Loss of Function RET Gene Variant and Cancer: Co-occurrence or an Association?

The Israel Medical Association journal, 2023-06, Vol.25 (6), p.445-446

2023

Volltextzugriff (PDF)

Secondary cancer after meningioma diagnosis: an Israeli national study

Cancer causes & control, 2022-10, Vol.33 (10), p.1277-1284

2022

Volltextzugriff (PDF)

Targeted genotyping for recurring variants in cancer susceptibility genes in non‐Ashkenazi Jewish patients with breast cancer diagnosed ≥50 years

Cancer, 2024-08, Vol.130 (16), p.2763-2769

2024

Volltextzugriff (PDF)

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

JNCI : Journal of the National Cancer Institute, 2017-07, Vol.109 (7)

2017

Volltextzugriff (PDF)

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

JAMA : the journal of the American Medical Association, 2015-04, Vol.313 (13), p.1347

2015

Volltextzugriff (PDF)

Yield of targeted genotyping for the recurring pathogenic variants in cancer susceptibility genes in a healthy, multiethnic Israeli population

Cancer, 2021-10, Vol.127 (19), p.3599-3604

2021

Volltextzugriff (PDF)

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

Human mutation, 2018-05, Vol.39 (5), p.593-620

2018

Volltextzugriff (PDF)

Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms

Breast cancer research and treatment, 2019-07, Vol.176 (1), p.165-170

2019

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(121)

Publikationsform

Artikel
(134)

Sprache

Englisch
(134)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Double heterozygosity for TP53 and BRCA1 mutations: clinical implications in populations with founder mutations

Activating genomic alterations in the Gs alpha gene (GNAS) in 274 694 tumors

Time trends in uptake rates of risk-reducing mastectomy in Israeli asymptomatic BRCA1 and BRCA2 mutation carriers

De novo pathogenic germline variant in PALB2 in a patient with pancreatic cancer

Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers

Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers

Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants

Breast cancer surveillance for BRCA1/2 mutation carriers – is “early detection” early enough?

Age at diagnosis of cancer in 185delAG BRCA1 mutation carriers of diverse ethnicities: tentative evidence for modifier factors

Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers

Cancer risks in Jewish male BRCA1 and BRCA2 mutation carriers

The risk for developing cancer in Israeli ATM, BLM, and FANCC heterozygous mutation carriers

Population‐based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants

The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation

Association between variants of 5-hydroxytryptamine receptor 3C (HTR3C) and chemotherapy-induced symptoms in women receiving adjuvant treatment for breast cancer

Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families

Phenotypes of carriers of two mutated alleles in major cancer susceptibility genes

Loss of Function RET Gene Variant and Cancer: Co-occurrence or an Association?

Secondary cancer after meningioma diagnosis: an Israeli national study

Targeted genotyping for recurring variants in cancer susceptibility genes in non‐Ashkenazi Jewish patients with breast cancer diagnosed ≥50 years

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

Yield of targeted genotyping for the recurring pathogenic variants in cancer susceptibility genes in a healthy, multiethnic Israeli population

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms

Suchergebnisse filtern